NCT02875223 2025-04-20A Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's LymphomasCelgenePhase 1 Terminated75 enrolled 35 charts
NCT04350463 2025-01-22A Safety and Efficacy Study of CC-90011 in Combination With Nivolumab in Subjects With Advanced CancersCelgenePhase 2 Completed92 enrolled 25 charts